COVID-19 patient treated with PBMT shows significant improvement
Category: #healthcare  By Mateen Dalal  Date: 2020-08-10
  • share
  • Twitter
  • Facebook
  • LinkedIn

COVID-19 patient treated with PBMT shows significant improvement

A laser therapy conducted at the Massachusetts Hospital has recently shown positive results for treating a patent suffering from COVID-19. The study led by Dr. Scott Sigman showed that the patient, following a Photobiomodulation Therapy (PBMT), showed significant improvement in respiratory indices, radiological results, oxygen requirements and outcomes without the need for a ventilator.

The 57-year-old African American patient that was diagnosed with COVID-19 was treated with a 28-minute PBMT session for four days using MLS (Multiwave Locked System) Therapy Laser. For the uninitiated, the MLS Therapy used in this study is offered exclusively in North America by Rochester-based Cutting Edge Laser Technologies. The response of PBMT on patients was studied by evaluating different scoring tools both prior and after laser therapy.

Before being treated with PBMT, the patient was bedridden and suffered with severe cough and inability to ambulate. However, following treatment, the patient's cough issue was resolved and was able to ambulate with physical therapy.

Speaking on the treatment, Dr. Sigman said that adjunct PBMT effectively treated respiratory issues in severe COVID-19 pneumonia cases and the therapeutic option comes as a feasible supportive treatment modality.

The need for safer and more effective COVID-19 treatment options still persists and there is hope that this study will encourage others to consider new clinical trials with the use of adjunct PBMT for treating COVID-19 pneumonia, he claims.

Generally, in PBMT, light is basked over damaged tissues, with light energy being absorbed by cells driving a cascade of molecular reactions that enhance cell function and improve the body's healing process.

PBMT has shown anti-inflammatory effects and is emerging as an alternative modality in pain management, wound healing, lymphedema treatment and musculoskeletal injuries.

Use of supportive PBMT for treating COVID-19 is based on the theory that laser light can reach the lung tissue to relieve inflammation and endorse healing. Also, PBMT comes as a non-invasive, cost-effective treatment with no known adverse effects.

Source Credit: https://www.prnewswire.com/news-releases/covid-19-pneumonia-patient-shows-significant-improvements-following-laser-treatment-at-massachusetts-hospital-301108558.html

About Author

Mateen Dalal    

Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunicat...

Read More>>

More News By Mateen Dalal

New York-based CRM startup Pico secures USD 6.5 million in funding
New York-based CRM startup Pico secures USD 6.5 million in funding
By Mateen Dalal

Pico, a New Yok-based audience development and creator monetization tools startup, has reportedly se...

Audi to take on Tesla with the launch of an entry-priced electric SUV
Audi to take on Tesla with the launch of an entry-priced electric SUV
By Mateen Dalal

Audi AG, the Germany-based multinational automotive manufacturer, has reportedly announced two new e...

Gennova begins enrollment for Phase 1/2 trials of mRNA COVID vaccine
Gennova begins enrollment for Phase 1/2 trials of mRNA COVID vaccine
By Mateen Dalal

India's first mRNA-based COVID-19 vaccine, HGCO19, formulated by Pune-based biotech firm, Gennov...